Company Filing History:
Years Active: 2023-2025
Title: Innovations by Shuaixiang Zhou
Introduction
Shuaixiang Zhou, an accomplished inventor based in Jiangsu, China, has made significant strides in the field of biotechnology. With a total of three patents to his name, his work focuses on the development of novel therapeutic proteins and antibodies that hold promise for treating various diseases.
Latest Patents
Among his latest inventions is an innovative interleukin-2 (IL-2) mutant protein that exhibits reduced IL-2Rα receptor binding ability and increased IL-2Rβ receptor binding ability compared to the wild-type IL-2. This groundbreaking invention encompasses a fusion protein and an immunoconjugate featuring the IL-2 mutant protein, along with a nucleic acid encoding the protein and the vectors required for its expression. Additionally, Zhou provides a method for preparing this IL-2 mutant protein, a pharmaceutical composition that employs it, and potential therapeutic applications.
Another notable patent by Zhou is centered around the anti-IL-23p19 antibody and its use in treating diseases. This invention includes a novel antibody and fragments that specifically bind to IL-23p19, complemented by a composition comprising these antibodies. The patent details the nucleic acid encoding this antibody or fragment, as well as the associated host cells, emphasizing their therapeutic and diagnostic applications.
Career Highlights
Shuaixiang Zhou has made a name for himself at Innovent Biologics (Suzhou) Co., Ltd., where his innovative work in the biotechnology sector continues to drive advancements. His dedication to research and development reflects his commitment to improving healthcare through innovative solutions.
Collaborations
Zhou collaborates with talented coworkers, including Junjian Liu and Zhiyuan Li, contributing to a dynamic work environment that fosters innovation and creativity. Their combined expertise enhances the potential for groundbreaking discoveries and advancements in biomedicine.
Conclusion
Through his inventive contributions in biotechnology, Shuaixiang Zhou exemplifies the impact of innovation in healthcare. His work on IL-2 mutant proteins and anti-IL-23p19 antibodies not only showcases his ingenuity but also promises to revolutionize treatment options for patients. As he continues to develop novel therapies, Zhou's future endeavors are anticipated with great interest in the scientific community.